Patel D, Ono S, Bassit L, Verma K, Amblard F, Schinazi R
Molecules. 2022; 27(17).
PMID: 36080181
PMC: 9457688.
DOI: 10.3390/molecules27175413.
Liao H, Cai D, Sun Y
Genome Biol. 2022; 23(1):38.
PMID: 35101081
PMC: 8801933.
DOI: 10.1186/s13059-022-02609-x.
Misbah M, Gupta P, Roy G, Kumar S, Husain M
Virusdisease. 2021; 32(3):480-491.
PMID: 34631975
PMC: 8473514.
DOI: 10.1007/s13337-021-00725-z.
Pour P, Fakhri S, Asgary S, Farzaei M, Echeverria J
Front Pharmacol. 2019; 10:1207.
PMID: 31787892
PMC: 6856223.
DOI: 10.3389/fphar.2019.01207.
Chen J, Shang J, Wang J, Sun Y
BMC Bioinformatics. 2019; 20(1):544.
PMID: 31684876
PMC: 6829986.
DOI: 10.1186/s12859-019-3138-1.
HIV drug resistance prediction with weighted categorical kernel functions.
Ramon E, Belanche-Munoz L, Perez-Enciso M
BMC Bioinformatics. 2019; 20(1):410.
PMID: 31362714
PMC: 6668108.
DOI: 10.1186/s12859-019-2991-2.
Precision epidemiology for infectious disease control.
Ladner J, Grubaugh N, Pybus O, Andersen K
Nat Med. 2019; 25(2):206-211.
PMID: 30728537
PMC: 7095960.
DOI: 10.1038/s41591-019-0345-2.
Modeling Cumulative Biological Phenomena with Suppes-Bayes Causal Networks.
Ramazzotti D, Graudenzi A, Caravagna G, Antoniotti M
Evol Bioinform Online. 2018; 14:1176934318785167.
PMID: 30013303
PMC: 6043942.
DOI: 10.1177/1176934318785167.
Effect of Education of Primary Health Care Workers on HIV-related Oral Lesions in Nairobi East District.
Koyio L, van der Sanden W, van der Ven A, Creugers N, Merkx M, Frencken J
J Public Health Res. 2014; 1(2):137-40.
PMID: 25181248
PMC: 4140363.
DOI: 10.4081/jphr.2012.e20.
Modeling-error robustness of a viral-load preconditioning strategy for HIV treatment switching.
Luo R, Piovoso M, Zurakowski R
Proc Am Control Conf. 2014; 2010:5155-5160.
PMID: 24954972
PMC: 4061758.
DOI: 10.1109/acc.2010.5530483.
Identifying the optimal dose of ritonavir in the treatment of malignancies.
Moawad E
Metab Brain Dis. 2013; 29(2):533-40.
PMID: 24248635
DOI: 10.1007/s11011-013-9448-5.
Emergence of drug resistance-associated mutations in HIV-1 subtype C protease gene in north India.
Azam M, Malik A, Rizvi M, Singh S, Gupta P, Rai A
Virus Genes. 2013; 47(3):422-8.
PMID: 23888308
DOI: 10.1007/s11262-013-0961-8.
Significantly improved HIV inhibitor efficacy prediction employing proteochemometric models generated from antivirogram data.
van Westen G, Hendriks A, Wegner J, IJzerman A, van Vlijmen H, Bender A
PLoS Comput Biol. 2013; 9(2):e1002899.
PMID: 23436985
PMC: 3578754.
DOI: 10.1371/journal.pcbi.1002899.
Closed-loop minimal sampling method for determining viral-load minima during switching.
Rosero-Garcia E, Zurakowski R
Proc Am Control Conf. 2012; 2010:460-461.
PMID: 23087541
PMC: 3475501.
DOI: 10.1109/acc.2010.5530993.
Differential in vitro kinetics of drug resistance mutation acquisition in HIV-1 RT of subtypes B and C.
Cunha R, Abreu C, Gonzalez L, Nijhuis M, De Jong D, Aguiar R
PLoS One. 2012; 7(10):e46622.
PMID: 23056372
PMC: 3463560.
DOI: 10.1371/journal.pone.0046622.
Approximate-model closed-loop minimal sampling method for HIV viral-load minima detection.
Zurakowski R, Churgin M, Perez C, Rodriguez M
Proc Am Control Conf. 2012; :5418-5419.
PMID: 23001383
PMC: 3445656.
DOI: 10.1109/acc.2011.5991281.
The human immunodeficiency virus-1 protease inhibitor nelfinavir impairs proteasome activity and inhibits the proliferation of multiple myeloma cells in vitro and in vivo.
Bono C, Karlin L, Harel S, Mouly E, Labaume S, Galicier L
Haematologica. 2012; 97(7):1101-9.
PMID: 22271897
PMC: 3396684.
DOI: 10.3324/haematol.2011.049981.
Controlling the Evolution of Resistance.
Luo R, Cannon L, Hernandez J, Piovoso M, Zurakowski R
J Process Control. 2011; 21(3):367-378.
PMID: 21516198
PMC: 3079266.
DOI: 10.1016/j.jprocont.2010.11.010.
Only slight impact of predicted replicative capacity for therapy response prediction.
Weisser H, Altmann A, Sierra S, Incardona F, Struck D, Sonnerborg A
PLoS One. 2010; 5(2):e9044.
PMID: 20140263
PMC: 2815793.
DOI: 10.1371/journal.pone.0009044.
Development and evaluation of a national reference panel of HIV-1 protease and reverse transcriptase drug-resistance mutations for HIV-1 genotypic resistance assays in China.
Xu S, Li J, Bao Z, Xing H, Zhong P, Li H
Mol Diagn Ther. 2010; 14(1):31-41.
PMID: 20121288
DOI: 10.1007/BF03256351.
